Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
JNJ Johnson & Johnson
- 152.360
- -2.440-1.58%
Close Dec 3 16:00 ET
- 152.400
- +0.040+0.03%
Post 18:00 ET
366.83BMarket Cap24.77P/E (TTM)
154.800High152.305Low8.67MVolume154.800Open154.800Pre Close1.33BTurnover0.36%Turnover Ratio11.10P/E (Static)2.41BShares167.50652wk High5.23P/B366.29BFloat Cap139.78952wk Low4.86Dividend TTM2.40BShs Float172.223Historical High3.19%Div YieldTTM1.61%Amplitude12.235Historical Low153.242Avg Price1Lot Size
About Johnson & Johnson Company
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Company Profile
SymbolJNJ
Company NameJohnson & Johnson
Listing DateSep 25, 1944
Founded1887
CEOMr. Joaquin Duato
MarketNYSE
Employees131900
Fiscal Year Ends12-31
AddressOne Johnson & Johnson Plaza
CityNew Brunswick
ProvinceNew Jersey
CountryUnited States of America
Zip Code08933
Phone1-732-524-0400
Websitehttp://www.jnj.com
Company Executives
- Name
- Position
- Salary
- Joaquin Duato
- Chairman of the Board and Chief Executive Officer
- 28.40M
- Joseph J. Wolk, C.P.A.
- Executive Vice President and Chief Financial Officer
- 13.91M
- Kristen Mulholland
- Chief Human Resources Officer
- --
- William N. Hait, M.D.,PhD
- Executive Vice President, Chief External Innovation and Medical Officer
- --
- Robert J. Decker, Jr
- Controller and Chief Accounting Officer
- --
- Kathryn E. Wengel
- Executive Vice President and Chief Technical Operations & Risk Officer
- --
- James D. Swanson
- Executive Vice President and Chief Information Officer
- --
- Vanessa Broadhurst
- Executive Vice President, Global Corporate Affairs
- --
- Elizabeth Forminard
- Executive Vice President and General Counsel
- --
- Timothy Schmid
- Executive Vice President and Worldwide Chairman, MedTech
- --
- Dr. John C. Reed,M.D.,PhD
- Executive Vice President, Innovative Medicine, R&D
- 20.65M
- Jennifer L. Taubert
- Executive Vice President and Worldwide Chairman, Innovative Medicine
- 11.00M
- Eugene A. Woods
- Independent Director
- 89.15K
- Dr. Jennifer A. Doudna, PhD
- Independent Director
- 320.00K
- Hubert Joly
- Independent Director
- 320.00K
- Dr. Paula A. Johnson,M.D.
- Independent Director
- 352.97K
- Mark A. Weinberger
- Independent Director
- 340.00K
- Dr. Mark B. McClellan, M.D.,PhD
- Independent Director
- 320.00K
- Marillyn A. Hewson
- Independent Director
- 360.00K
- Dr. Mary C. Beckerle, PhD
- Independent Director
- 355.00K
- Anne M. Mulcahy
- Lead Independent Director
- 410.00K
- Dr. Nadja Y West, M.D.
- Independent Director
- 340.00K
- Darius E. Adamczyk
- Independent Director
- 340.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
